Trial Profile
Efficacy of Crizotinib In Advanced, Chemoresistant ALK+ Lymphoma Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2014
Price :
$35
*
At a glance
- Drugs Crizotinib (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Expanded access; Therapeutic Use
- 04 Aug 2014 New trial record
- 09 Dec 2013 Interim results presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.